Genmab A/S (GMAB)

Genmab A/S has recorded no insider trading activity within the last 90 days. The most recent transaction occurred on February 19, 2026, when Executive Vice President and CFO Anthony Pagano sold 1,100 shares. Prior activity includes sales by board members and directors dating back to 2025.
Ticker: GMAB Exchange: CPH


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Genmab A/S. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Sale 19 Feb 2026
Value DKK3,029,783.39 | Price 130.52 | Shares 85,982
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-20 2026-02-19 S Sale

Executive Vice President & Chief Financial Officer

Officer
85,982
130.52
DKK3,029,783
85,982 130.52 DKK3,029,783
2025-11-19 2025-11-19 S Sale

Member of the Board of Directors

Executive Director
2,513
354.21
DKK1,818,883
2,513 354.21 DKK1,818,883
2025-06-17 2025-06-17 PrS Proposed sale

Director

Non-Executive Director
80,815
378.04
US$1,578,430
80,815 378.04 US$1,578,430
2024-03-01 2024-03-01 PrS Proposed sale

Officer

Officer
1,200
275.00
US$330,000
1,200 275.00 US$330,000